Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Oxidative stress could be involved in the pathophysiology of schizophrenia, a major psychiatric disorder. Glutathione (GSH), a redox regulator, is decreased in patients' cerebrospinal fluid and prefrontal cortex. The gene of the key GSH-synthesizing enzyme, glutamate cysteine ligase modifier (GCLM) subunit, is strongly associated with schizophrenia in two case-control studies and in one family study. GCLM gene expression is decreased in patients' fibroblasts. Thus, GSH metabolism dysfunction is proposed as one of the vulnerability factors for schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several divergent genetic (e.g. Gclc, Gclm, Disc1, PRODH, G72, NRG1) (9–17) or external factors (e.g. stress, social isolation, ketamine, neonatal ventral hippocampal lesion) (18–24) collectively lead to redox dysregulation.”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [10]
In the citing paper
“Genetic analysis of single nucleotide polymorphisms in schizophrenia patients demonstrates mutations in the gene encoding GCL, an enzyme that is important for the production of the cellular antioxidant GSH (Tosic et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Tosic et al., 2006
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_5485 · Cited by 10,169
Meister, A., & Anderson, M. E. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003431 · Cited by 5,680
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Diagnostic Interview for Genetic Studies: Rationale, Unique Features, and Training
Nurnberger, J. I. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110009002 · Cited by 2,053
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
Schizophrenia: genes and environment
Tsuang, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00289-9 · Cited by 597
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · cited 1×
“This is strikingly similar to the levels 52% below normal reported for patients with schizophrenia.(15) Thus, GCLM KO mice can be used as a model for further studies of GSH deficit in schizophrenia.”
ResultSelf-citationPrabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001532 · Cited by 375
Huang, C. S., Chang, L. S., Anderson, M. E., & Meister, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36569-x · Cited by 374
Free radical pathology and antioxidant defense in schizophrenia: a review
Mahadik, S. P., & Mukherjee, S. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00049-6 · Cited by 330
Altered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321
Altar, C. A., Jurata, L. W., Charles, V., Lemire, A., Liu, P., Bukhman, Y., Young, T. A., Bullard, J., Yokoe, H., Webster, M. J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.031 · Cited by 318
Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse
Yang, Y., Dieter, M. Z., Chen, Y., Shertzer, H. G., Nebert, D. W., & Dalton, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209372200 · Cited by 269
NMDA receptor channels: Subunit-specific potentiation by reducing agents
Köhr, G., Eckardt, S., Lüddens, H., Monyer, H., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90311-5 · Cited by 257
Kolluri, N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1200 · Cited by 241
Herken, H., Uz, E., Özyurt, H., Söğüt, S., Virit, O., & Akyol, Ö. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000789 · Cited by 238
Huang, C. S., Anderson, M. E., & Meister, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80764-9 · Cited by 237
Glutamate Cysteine Ligase Catalysis
Chen, Y., Shertzer, H. G., Schneider, S. N., Nebert, D. W., & Dalton, T. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504604200 · Cited by 234
Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173
Self-citationRedox modulation of the NMDA receptor
Choi, Y.-B., & Lipton, S. A. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000638 · Cited by 165
Nakamura, S.-I., Kugiyama, K., Sugiyama, S., Miyamoto, S., Koide, S.-I., Fukushima, H., Honda, O., Yoshimura, M., & Ogawa, H. (2002) · Circulation · doi:10.1161/01.cir.0000019739.66514.1e · Cited by 160
Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia
Grima, G., Benz, B., Parpura, V., Cuénod, M., & Do, K. Q. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00405-x · Cited by 156
NMDA Receptor Function, Neuroplasticity, and the Pathophysiology of Schizophrenia
Coyle, J. T., & Tsai, G. E. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59019-0 · Cited by 148
A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress
Marchbanks, R. M., Ryan, M., Day, I. N. M., Owen, M., McGuffin, P., & Whatley, S. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00011-2 · Cited by 101
Pulver, A. E., Mulle, J. G., Nestadt, G., Swartz, K., Blouin, J., Dombroski, B. A., Liang, K.-Y., Housman, D. E., Kazazian, H. H., Antonarakis, S. E., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000814 · Cited by 98
Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96
Self-citationArinami, T., Ohtsuki, T., Ishiguro, H., Ujike, H., Tanaka, Y., Morita, Y., Mineta, M., Takeichi, M., Yamada, S., Imamura, A., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/498122 · Cited by 93
Role of Endogenous Glutathione in the Oxidation of Dopamine
Rabinovic, A. D., & Hastings, T. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052071.x · Cited by 82
Do, K. Q., Lauer, C. J., Schreiber, W., Zollinger, M., Gutteck‐Amsler, U., Cuénod, M., & Holsboer, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062652.x · Cited by 79
Self-citationA Strategy for the Rapid Discovery of Disease Markers Using the MassARRAY ™ System
Rodi, C. P., Darnhofer-Patel, B., Stanssens, P. E., Zabeau, M., & van den Boom, D. (2002) · BioTechniques · doi:10.2144/jun0204 · Cited by 74
Castagné, V., Rougemont, M., Cuenod, M., & Do, K. Q. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.005 · Cited by 71
Self-citationA strategy for the rapid discovery of disease markers using the MassARRAY system.
Rodi, C. P., Darnhofer-Patel, B., Stanssens, P. E., Zabeau, M., & van den Boom, D. (2002) · PubMed · Cited by 69
Harada, S., Tachikawa, H., & Kawanishi, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4347 · Cited by 62
Castagné, V., Cuénod, M., & Do, K. Q. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.012 · Cited by 53
Self-citationTsuchiya, K. D., Mulcahy, R., Reid, L. L., Distèche, C. M., & Kavanagh, T. J. (1995) · Genomics · doi:10.1006/geno.1995.1293 · Cited by 50
Glutathione S-transferase M1 polymorphism may contribute to schizophrenia in the Korean population
Pae, C., Yu, H.-S., Kim, J.-J., Kim, W. B., Lee, C., Lee, S.-J., Jun, T., Lee, C., Paik, I., & Serretti, A. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200409000-00005 · Cited by 34
Pae, C., Kim, J.-J., Lee, S.-J., Lee, C., Lee, C., Paik, I., Park, H. R., Yang, S. Y., & Serretti, A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00043-5 · Cited by 23
Shinkai, T., Luca, V. D., Zai, G. C., Shaikh, S. A., Matsumoto, C., Arnold, P. D., Hwang, R., King, N. A., Trakalo, J., Potapova, N., et al. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200409000-00012 · Cited by 18
Dysregulation of glutamate cysteine ligase in schizophrenia
Gysin, R., Toŝić, M., Chappuis, C., Deppen, P., Ruiz, V., Bovet, P., Cuénod, M., & Kim, Q. (2005) · IRIS · Cited by 3
Self-citation
Research works printed but not linked: 1
- Cabungcal, 2004, Special bias deficit in rats with low glutathione during development: a behaviour model with relevance to schizophrenia, Schizophr Res, 67, 118
Cited by
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
“Genetic polymorphisms of antioxidant enzymes, associated with psychiatric disorders (Akyol et al., 2005; Saadat et al., 2007; Tosic et al., 2006), may have potential in assisting the identification of at-risk individuals.”
BackgroundGawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594
“Others have found that GCL alterations modulate GSH levels (Lavoie et al. 2009), this enzyme’s gene is a potential susceptibility gene in SCZ (Tosic et al. 2006), and its expression is affected by mood-stabilizer treatment (Cui et al. 2007).”
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.165 · Cited by 543
Metadata
- Authors
- Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., Solida, A., Timm, S., Wang, A. G., Werge, T., Cuénod, M., & Quang Do, K.
- Affiliations
- Rockefeller University (US)
- Centre Hospitalier Universitaire Vaudois (CH)
- Hvidovre Hospital (DK)
- Frederiksberg Hospital (DK)
- Amager Hospital (DK)
- Sankt Hans Hospital (DK)
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 79
- Issue
- 3
- Pages
- 586-592
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1559555
- OpenAlex
- W2039366241
- Cited by
- 234
- References
- 43
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 6 · 2023: 12 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 9 · 2018: 6 · 2017: 16 · 2016: 12 · 2015: 8 · 2014: 21 · 2013: 10 · 2012: 15
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2513 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (R01MH044292, MH 44292, R37MH044292)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- schizophrenia, oxidative stress, GCLM, glutathione metabolism, glutathione, genetic susceptibility, redox regulation, cerebrospinal fluid, prefrontal cortex, fibroblast gene expression
- MeSH terms
- Fibroblasts, Glutamate-Cysteine Ligase, Gene Frequency, Glutathione, Humans, RNA, Messenger, Schizophrenia, Down-Regulation, Case-Control Studies, Oxidative Stress, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.